Search Results

To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.

The Laurie K. Lacob Pavilion at the Stanford Medicine Cancer Center opened July 17. The state-of-the-art facility, for transplant and cellular therapies, is a light-filled space for healing.

An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

The structure of a critical cellular-signaling molecule has finally been discovered by Stanford researchers. The finding may lead to new therapies.

Two anti-cancer antibodies have a much stronger effect against pediatric nerve-cell and bone cancers in mice than either one alone, researchers have discovered.

The Stanford Cancer Institute is one of 51 National Cancer Institute-designated comprehensive cancer centers, which must meet rigorous standards for improving the prevention, diagnosis and treatment of cancer.

Stanford researcher Maria Grazia Roncarolo has been awarded $12 million by the California Institute for Regenerative Medicine for a trial aimed at improving the outcomes of stem cell transplants in children and young adults with blood cancers.